Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Scheidemantel

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neuropsychiatric Disease and Treatment|December 18, 2015
Asenapine for bipolar disorderThomas Scheidemantel, Irina Korobkova, Soham Rej, et al.
Journal of Gambling Studies|January 24, 2019
Playing with a Stacked Deck: Literature Review and Case Series of Problem Gambling in Adults with Intellectual and Developmental DisabilitiesThomas Scheidemantel, Ashley Braun-Gabelman, Kristina Stefanac, et al.
Archives of Pathology & Laboratory Medicine|December 1, 2012
Two cases of Cokeromyces recurvatus in liquid-based Papanicolaou tests and a review of the literatureShelley I Odronic, Thomas Scheidemantel, Marion J Tuohy, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 1, 2015
Comparing Patient-Reported Outcomes Measure Information System Depression Scale with Legacy Depression Measures in a Community Sample of Older Adults with Varying Levels of Cognitive FunctioningJennifer B Levin, Michelle E Aebi, Kathleen A Smyth, et al.
Psychiatric Rehabilitation Journal|August 31, 2018
Race analysis in an African American sample with serious mental illness and comorbid diabetesMartha Sajatovic, Molly Howland, Douglas Gunzler, et al.
Brain Sciences|November 27, 2025
Baseline Neuropsychological Characteristics of Adolescents and Young Adults with Down Syndrome Who Participated in Two Clinical Trials of the Drug MemantineAlberto C S Costa, Ana C Brandão, Veridiana Leiva, et al.
The Lancet. Neurology|December 23, 2021
Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trialAlberto C S Costa, Ana C Brandão, Richard Boada, et al.
Journal of Clinical Medicine|April 30, 2021
Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) StudyJames A Hendrix, David C Airey, Angela Britton, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neuropsychiatric Disease and Treatment|December 18, 2015
Asenapine for bipolar disorderThomas Scheidemantel, Irina Korobkova, Soham Rej, et al.
Journal of Gambling Studies|January 24, 2019
Playing with a Stacked Deck: Literature Review and Case Series of Problem Gambling in Adults with Intellectual and Developmental DisabilitiesThomas Scheidemantel, Ashley Braun-Gabelman, Kristina Stefanac, et al.
Archives of Pathology & Laboratory Medicine|December 1, 2012
Two cases of Cokeromyces recurvatus in liquid-based Papanicolaou tests and a review of the literatureShelley I Odronic, Thomas Scheidemantel, Marion J Tuohy, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 1, 2015
Comparing Patient-Reported Outcomes Measure Information System Depression Scale with Legacy Depression Measures in a Community Sample of Older Adults with Varying Levels of Cognitive FunctioningJennifer B Levin, Michelle E Aebi, Kathleen A Smyth, et al.
Psychiatric Rehabilitation Journal|August 31, 2018
Race analysis in an African American sample with serious mental illness and comorbid diabetesMartha Sajatovic, Molly Howland, Douglas Gunzler, et al.
Brain Sciences|November 27, 2025
Baseline Neuropsychological Characteristics of Adolescents and Young Adults with Down Syndrome Who Participated in Two Clinical Trials of the Drug MemantineAlberto C S Costa, Ana C Brandão, Veridiana Leiva, et al.
The Lancet. Neurology|December 23, 2021
Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trialAlberto C S Costa, Ana C Brandão, Richard Boada, et al.
Journal of Clinical Medicine|April 30, 2021
Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) StudyJames A Hendrix, David C Airey, Angela Britton, et al.
Pageof 1